Risk Factors for Testicular Cancer in a 35-Year-Old Male Athlete
The most likely risk factor for testicular cancer in a 35-year-old male athlete is previous cryptorchidism (undescended testis), not testicular torsion or testosterone supplement use. 1
Established Risk Factors for Testicular Cancer
Testicular cancer is the most common solid malignancy among males aged 15-40 years, with a mean age at diagnosis of 33 years 2. Understanding the risk factors is crucial for early identification and management.
Primary Risk Factors (In Order of Strength of Association)
Cryptorchidism (undescended testis):
Family history of testicular cancer:
Previous testicular cancer:
Testicular dysgenesis/abnormal testicular development 1
Infertility:
Other Considerations
- Age: Testicular cancer is most common in men aged 15-40 years 2
- Testicular atrophy: Volumes <12 ml are associated with higher risk 3
Addressing the Options in the Question
Previous testicular torsion: Not established as a significant risk factor in major guidelines. While trauma has been studied, a case-control study showed no significant association after accounting for recall bias 5.
Use of testosterone supplements: Not listed as a risk factor in ESMO or NCCN guidelines 1. There is no established causal relationship between testosterone supplementation and testicular cancer development.
Recurrent epididymorchitis: Not established as a significant risk factor in major guidelines. While inflammation might be associated with some cancers, there is insufficient evidence to support epididymorchitis as a risk factor for testicular cancer.
Clinical Implications
For a 35-year-old male athlete with testicular cancer:
- Evaluate for history of cryptorchidism
- Consider family history of testicular cancer
- Assess for testicular atrophy or signs of testicular dysgenesis
- Evaluate fertility status as it may be both a risk factor and affected by the disease
Early diagnosis and proper staging are critical, including tumor markers (AFP, β-HCG, LDH) and appropriate imaging studies 3.
Understanding these risk factors can help with risk stratification and appropriate follow-up, especially given the excellent survival rates (97% overall five-year survival) with proper treatment 6.